TGF-beta: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention.
Border
W A
WA
Division of Nephrology, University of Utah School of Medicine, Salt Lake City, USA.
Noble
N A
NA
Ketteler
M
M
D000208:Acute Disease; D000818:Animals; D002908:Chronic Disease; D016207:Cytokines / Q000502:physiology*; D005921:Glomerulonephritis / Q000503:physiopathology; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D012084:Renin-Angiotensin System; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors* / Q000502:physiology*
D016207:Cytokines; D016212:Transforming Growth Factor beta